Preview

Experimental and Clinical Gastroenterology

Advanced search

Clinical features of the course of polyarteritis nodosa in combination with familial Mediterranean fever

https://doi.org/10.31146/1682-8658-ecg-217-9-231-237

Abstract

There are certain difficulties with diagnosing of poliarteritis nodoza, that is explained by the folllowung factors: non-specificity of the initial symptoms, polymorphism of clinical manifestations, the abcence of specific laboratory markers. Тhe diagnosis is made primarily on the basis of the clinical picture, that becomes apparent during the first three months of illness. The abcence of a detailed clinical picture does not exclude the presense of poliarteritis nodoza. It may be explained by the concomitant pathology, in this case periodic illness (familian mediterranean fever). Due to medical literature data, poliarteritis nodoza is surely associated with periodic illness. The prevalence of poliarteritis nodoza in general population is about 6 on 100 000 people.The prevalence of poliarteritis nodoza among the patients suffering from periodic illness is 1%. The patients when they are diagnosed polyarteritis nodosa in association with periodic illness are younger than the patients when they are diagnosed only polyarteritis nodosa. It turned out to be interesting that the treatment of patients with polyarteritis nodosa in association with periodic illness through glucocorticoid drugs in the combination with colchicines proved to be successful and resulted in remission.

About the Authors

L. P. Petrosyan
Central Clinical Military Hospital
Russian Federation


M. V. Sargsyan
Erevan State Medical University after Mkhitar Heratsi
Russian Federation


V. O. Petrosyan
Central Clinical Military Hospital
Russian Federation


V. N. Mukuchyan
Nairi Medical Center
Russian Federation


References

1. Amaryan G. G. Periodic disease (Familial mediterranean fever) in children. Meditsinskiy sovet = Medical Council. 2017;(19):222-228. (In Russ.) doi: 10.21518/2079-701X-2017-19-222-228.@@ Амарян Г. Г. Периодическая болезнь (Семейная средиземноморская лихорадка) у детей. Медицинский Совет. 2017;(19):222-228. doi: 10.21518/2079-701X-2017-19-222-228.

2. Bakalets N. F., Pronevich A. V. A Clinical case of polyarteritis nodosa. Health and Ecology Issues. 2017;(4):83-87. (In Russ.) doi: 10.51523/2708-6011.2017-14-4-18.@@ Бакалец Н. Ф., Проневич А. В. Клинический случай узелкового полиартериита. Проблемы здоровья и экологии. 2017;(4):83-87. doi: 10.51523/2708-6011.2017-14-4-18.

3. Karpov V. V., Abaeva N. G., Disenbaeva L. G., Hatunceva L. A. The case of polyarteritis nodosa at the girl of 17 years. Zhurnal fundamental’noy meditsiny i biologii = Journal of Fundamental Medicine and Biology. 2014;(1):69-71. (in Russ.)@@ Карпов В.В, Абаева Н.Г, Дисенбаева Л.Г, Хатунцева Л. А. Случай узелкового полиартериита у девочки 17 лет. Журнал фундаментальной медицины и биологии. - 2014, - № 1, - С. 69-71.

4. Logvinenko S. I., Efremova O. A., Pridachina L. S., Shcherban E. A., Romanova A. V., Sviridov A. A. Polyarteritis nodosa (Kussmaul-Maier disease) - the difficult diagnosis in the practice of practitioner. Series Medicine.Pharmacy. 2014;182(26):258-260. (in Russ.)@@ Логвиненко С.И, Ефремова О. А., Придачина Л. С, Щербань Э.А, Романова А. В., Свиридов А. А. Узелковый полиартериит (Болезнь Куссмауля-Мейера) - трудный диагноз в практике врача-терапевта /Научные ведомости Белгородского государственного медицинского университета. Серия Медицина.Фармация. 2014. -№ 11 (182) Выпуск 26. - С. 258-260.

5. Murkamilov I. T., Aitbaev K. A., Fomin V. V., Yusupov F. A. Polyarteritis nodosa: prevalence, risk factors, and treatment options (literature review and clinical observation). The scientific heritage. 2020;47(2):31-39. (in Russ.)@@ Муркамилов И. Т., Айтбаев К. А., Фомин В. В., Юсупов Ф. А. Узелковый полиартериит: распространенность, факторы риска и возможности терапии (обзор литературы и клиническое наблюдение). The scientific heritage N0 47 (2020) С 31-39.

6. Nasonov E. L. Rheumatology: Clinical guidelines. Systemic vasculitis. Moscow. GEOTAR-Media Publ., 2005. pp. 203-213.@@ Насонов Е. Л. Ревматология: Клинические рекомендации. Системные васкулиты / под редакцией академиак РАМН Е. Л. Насонова. - М: ГЭОТАР- Медиа, 2005. С. 203-213 /

7. Fidder H., Chowers Y., Ackerman Z., et al. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn’s disease. Am J Gastroenterol. 2005 Feb;100(2):338-43. doi: 10.1111/j.1572-0241.2005.40810.x.

8. Gershoni-Baruch R., Brik R., Zacks N., Shinawi M., Lidar M., Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 2003 Apr;48(4):1149-55. doi: 10.1002/art.10944.

9. Kallinich T., Haffner D., Niehues T., et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007 Feb;119(2): e474-83. doi: 10.1542/peds.2006-1434.

10. Lightfoot R. W. Jr, Michel B. A., Bloch D. A., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990 Aug;33(8):1088-93. doi: 10.1002/art.1780330805.


Review

For citations:


Petrosyan L.P., Sargsyan M.V., Petrosyan V.O., Mukuchyan V.N. Clinical features of the course of polyarteritis nodosa in combination with familial Mediterranean fever. Experimental and Clinical Gastroenterology. 2023;(9):231-237. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-217-9-231-237

Views: 292


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)